Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity

CONTEXT: Hypothalamic injury often leads to rapid, intractable weight gain causing hypothalamic obesity, which is associated with increased risk of cardiovascular and metabolic morbidity and mortality. There are no approved or effective pharmacological treatments for hypothalamic obesity, and conven...

Descripción completa

Detalles Bibliográficos
Autores principales: Huynh, Kim, Klose, Marianne, Krogsgaard, Kim, Drejer, Jørgen, Byberg, Sarah, Madsbad, Sten, Magkos, Faidon, Aharaz, Abdellatif, Edsberg, Berit, Tfelt-Hansen, Jacob, Astrup, Arne Vernon, Feldt-Rasmussen, Ulla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2022
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175551/
https://www.ncbi.nlm.nih.gov/pubmed/35294397
http://dx.doi.org/10.1530/EJE-21-0972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175551/
https://www.ncbi.nlm.nih.gov/pubmed/35294397
http://dx.doi.org/10.1530/EJE-21-0972

Ejemplares similares